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Abstract: Contingency management (CM) is 
a general behavioural intervention technique 
used in the treatment of drug dependence to 
systematically arrange consequences and it is 
designed to weaken drug use and strengthen 
abstinence. 
The main elements of CM interventions 
are behavioural reinforcers and monitoring, 
which aim to promote social reintegration by 
sustaining compliance, abstinence and/or 
attendance at work.
We performed a systematic review of 
studies on the effectiveness of CM alongside 
pharmacological treatment of dependence. 
We included 38 studies on opioid users 
(n = 20), cocaine users in methadone 
therapy (n = 14), cocaine users (n = 3) and 
methamphetamine users (n = 1). We found 
that CM was useful for reducing drug use 
among cocaine users and opioid users in 
substitution treatment for reducing and 
abstaining from cocaine use. In opioid 
detoxification, CM increased retention in 
treatment and improved abstinence. In terms 
of the cost-effectiveness of CM, the evidence 
is not strong enough to recommend its 
systematic implementation.
We included three studies on the economic 
analysis with evidence for cost-effectiveness 
analysis: one review (based upon nine 
published studies) and two additional studies. 
The review confirms that evidence for cost-
effectiveness has limited generalisability 
beyond original research.
Our limited analysis shows that CM is a 
feasible and promising adjunct to treatment 
interventions for drug users. 
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I  Background
I Description of the interventions
Contingency management (CM) is a general behavioural 
intervention technique used in the treatment of drug 
dependence that aims to alter drug use by systematically 
arranging consequences; this technique is designed to weaken 
drug use and strengthen abstinence (Griffith et al., 2000).
CM is one key element of a broader behavioural approach 
belonging to the theory of operant conditioning (West, 
2013). Operant conditioning assumes that individuals are 
conditioned by the consequences of their behaviour. Pleasant 
consequences reinforce some behaviours and punishment 
discourages them. This model originates from the experiments 
of Burrhus Frederic Skinner (1938) on learning processes 
in animals, in which he noticed that behaviours that are not 
reinforced are easily abandoned.
Various techniques are derived from operant conditioning 
theory, including techniques to shape the behaviour of pupils 
in the classroom (Altman and Linton, 1971), psychiatric 
hospital inpatients (in particular through the token economy 
system (Ayllon and Azrin, 1968)) and drug users (Weaver et al., 
2014).
In drug addiction studies, operant conditioning theory has 
implications for the explanation of the development of 
addiction and for the strategies used to prevent it and to 
promote recovery (West, 2013).
The main elements of CM interventions are targeted 
contingency, behavioural reinforcers and monitoring. The 
ultimate goal of CM is to promote social reintegration by 
sustaining compliance, abstinence and/or attendance at 
work. Reinforcers are benefits, which can be cash, vouchers, 
prizes or other kinds of perceived privileges, such as taking 
home doses of methadone (Higgins et al., 2004; Petry, 2000; 
Stitzer and Petry, 2006). The patient will gain or lose reinforcers 
according to whether he/she can consistently and regularly 
achieve the expected outcomes or not. The duration of the CM 
intervention can vary. For example, we found that descriptions 
of interventions ranged from 8 weeks (Petry, 2000) to 52 weeks 
(Silverman et al., 2004). CM has been used in many types of 
addictive behaviour. It has been extensively used in different 
substance use disorders, such as problematic use of marijuana 
(Stanger et al., 2009), opioids (Chopra et al., 2009) and 
cocaine (Barry et al., 2009; Silverman et al., 2004), as well as in 
nicotine dependence (Yi et al., 2008), methamphetamine use 
disorders (Roll et al., 2006), alcohol dependence (Petry, 2000) 
and polydrug abuse (Silverman et al., 2002).
For the treatment of substance use disorders, CM is provided, 
for example, in detoxification clinics, psychosocial counselling 
services and methadone maintenance programmes (Stitzer 
and Petry, 2006).
CM approaches, whereby rewards (e.g. cash, vouchers, prizes 
or other privileges such as therapy delivered at home) are 
contingent on successfully performing a particular activity (e.g. 
getting a job, providing a substance-negative urine sample, 
participating in a screening) (Figure 1) showed some promising 
results for substance-dependent patients in the USA. Their 
application might raise particular ethical concerns in the EU 
(EMCDDA, 2012); nevertheless, the UK National Institute for 
Health and Care Excellence (NICE) (Table 1) recommends that 
CM should be applied and assessed in routine clinical practice 
in the UK, identifying specific targets for application, such as 
increasing patients’ compliance with testing for infectious 
diseases (Weaver et al., 2014).
FIGURE 1
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TABLE 1
Examples of resources used to deliver and implement 
contingency management interventions
Country Resource Website
International WHO ‘Guidelines 
for identification 
and management 
of substance use 
and substance use 





guidelines/en/ (date of 
publication: 2014)
UK The Public Health 
England website 
has a collection 










guidance/cg120 (date of 
publication: 2011)
USA ‘Medication-assisted 
treatment for opioid 






(date of last edition 2014)
I How the interventions may work
It has been noted that ‘reinforcement processes play a central 
role in the genesis, maintenance, and recovery from substance 
use disorders’ (Higgins et al., 2004). CM is supposed to 
interfere with the drug-related reinforcement cycle by 
introducing a competitive source of rewarding (Higgins et al., 
2004; Stitzer and Petry, 2006). When the reinforcement power 
of the incentives prevails over the effect of the abused drugs, 
human behaviour consequently should change. During the 
process of continuous rehabilitation, CM interventions help 
to decrease the sensitivity of drug users to substance-related 
environments (Stitzer and Petry, 2006).
I Why is this review important?
Many studies (including systematic reviews and meta-
analyses) have been published on the use of CM for substance 
use disorders (Barry et al., 2009; Benishek et al., 2014; 
Chopra et al., 2009; Farronato et al., 2013; Griffith et al., 2000; 
Prendergast et al., 2006; Petry, 2000; Petry and Simcic, 2002; 
Petry et al., 2010; Schierenberg et al., 2012), with a focus on 
the effectiveness of the CM application and generalisation.
Several Cochrane systematic reviews have assessed the 
efficacy of psychosocial interventions, which also include CM 
for substance use disorders (Amato et al., 2011a,b; Denis 
et al., 2013; Knapp et al., 2007; Lui et al., 2008; Mayet et al., 
2014). However, these reviews included studies on a specific 
substance of abuse and dependence, assessing the effects 
of CM in combination with other psychosocial interventions. 
A protocol of a Cochrane review has been published on this 
topic, but results are not yet available (Pan et al., 2012).
CM can be a suitable intervention to support the social 
reintegration of patients; nevertheless, a comprehensive review 
of the available studies is needed to enable decision-making. 
This review should also consider the economic aspect to 
determine if CM would add sufficient value to justify its costs.
I Objectives
The objectives of this review are:
 § to assess the effectiveness of the CM approach in 
combination with substitution treatment or detoxification 
for drug-dependent people by assessing whether or not 
there is an increase in the retention of patients in treatment, 
in patients achieving abstinence or reducing their use 
of substances, in patients’ participation in screening 
programmes for the detection of human immunodeficiency 
virus (HIV) and hepatitis B and C virus infection, and in 
patients’ participation in hepatitis B virus vaccination 
programmes;
 § to provide an updated synthesis of the studies on the costs 




We included published articles with the objective of evaluating 
the effectiveness of CM in treating drug use addiction that 
were based on randomised clinical trials and quasi randomised 
controlled trials and studies that looked at the costs associated 
with implementing these CM interventions.
A particular CM intervention used for treating drug use can 
be considered economically efficient if its monetary benefits 
exceed its monetary costs. The most succinct measure 
of economic efficiency is the cost–benefit ratio, which is 
a measure of the benefit derived from the investment of 
a single monetary unit. Cost-effectiveness studies provide 
the cost information of an option in monetary terms and the 
outcomes in non-monetary terms. The most usual outcome 
measure used in cost-effectiveness studies on the treatment 
of drug use addictions is reductions in use or abstinence. 
Treatment retention, treatment compliance and mental health 
status are also considered, as secondary outcomes.
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We excluded non-empirical articles; specifically narrative 
literature reviews and commentaries were excluded.
Types of participants
Adult (≥18 years old) individuals that were dependent 
(according to DSM-IV (the fourth edition of the Diagnostic and 
Statistical Manual of Mental Disorders) or ICD 10 (the 10th 
edition of the International Statistical Classification of Diseases 
and Related Health Problems)) on any illicit substance 
(opioids, cocaine, amphetamine/methamphetamines, 
marijuana) or patients with polysubstance dependence were 
included; patients with tobacco and/or alcohol dependence 
only were excluded.
Types of interventions
The experimental intervention was CM in combination with 
any pharmacological treatment (opioid substitution treatment 
(OST), detoxification). The control intervention was any 
pharmacological treatment without CM.
Types of outcomes
The primary outcomes were patients’ retention in treatment, use 
of the main substance of abuse (based on self-reported data 
and urine analysis or other biochemical markers), monetary 
units, cost–benefit ratios, cost-effectiveness ratios, incremental 
cost-effectiveness ratios (ICERs) and acceptability curves.
The secondary outcomes were the use of other substances 
(based on self-reported data and urine analysis or other 
biochemical markers), relapse prevention, participation 
in screening programmes for HIV, hepatitis B and C virus 
infections, overall mortality and overdoses.
I Search strategy
Electronic searches for the identification of studies
We searched the following electronic databases when looking 
for studies about the effectiveness of CM:
 § Cochrane Drugs and Alcohol Group’s specialised register of 
trials (September 1998 to September 2014);
 § Cochrane Central Register of Controlled Trials (CENTRAL; 
The Cochrane Library, September 2014);
 § PubMed (January 1966 to September 2014);
 § EMBASE (embase.com) (January 1974 to September 
2014);
 § CINAHL (EbscoHOST) (1982 to September 2014);
 § ISI Web of Science (September 2005 to September 2014).
We searched these databases using MeSH and free-text terms 
relating to substance use disorders and CM. We combined 
the PubMed search with the Cochrane Highly Sensitive 
Search Strategy for identifying randomised trials in MEDLINE: 
sensitivity maximising version (2008 revision) (Lefebvre et 
al., 2011). Detailed search strategies were developed for 
each database used, accounting for differences in controlled 
vocabulary and syntax rules. The detailed search strategies are 
shown in Annex 1.
We searched the following electronic databases when looking 
for studies on costs and cost efficiency:
 § Cochrane Drugs and Alcohol Group’s specialised register of 
trials;
 § Cochrane Central Register of Controlled Trials (CENTRAL; 
The Cochrane Library, most recent issue);
 § MEDLINE (2000 onwards);
 § PubMed;
 § British Library ‘on demand’;
 § EconLit;
 § NHS Economic Evaluation Database;
 § ResearchGate.
We searched these databases using MeSH and free-text 
terms relating to substance use disorders and CM. Detailed 
search strategies were developed for each database used, 
accounting for differences in controlled vocabulary and syntax 
rules. Since the structure of costs changes considerably over 
time, it was considered of limited relevance to look for articles 




 § the reference lists of all relevant papers to identify further 
studies;
 § some of the main electronic sources of ongoing trials 
(including the World Health Organization (WHO) 
International Clinical Trials Registry Platform (www.who.
int/ictrp) and; the UK Clinical Trials Gateway (https://www.
ukctg.nihr.ac.uk/);
 § conference proceedings that were likely to contain trials 
relevant to the review (e.g. of the College on Problems of 
Drug Dependence (CPDD));
 § national focal points for drug research (e.g. the National 
Institute of Drug Abuse (NIDA) and the National Drug and 
Alcohol Research Centre (NDARC)).
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Authors of included studies and experts in the field in various 
countries were contacted to find out if they knew of any other 
published or unpublished controlled trials. No language 
restrictions were applied.
I Data collection and analysis
Selection of studies
Two authors independently screened titles and abstracts of 
studies obtained by the search strategy and agreed on the 
preliminary selection. The full-text version of each potentially 
relevant study located in the search was obtained and 
assessed for inclusion independently by two authors. In the 
case of disagreement, a third author was consulted.
Data extraction and management
Data were extracted independently by two authors. Any 
disagreement was discussed and solved by consensus.
Assessment of the risk of bias in included studies
The assessment of the risk of bias for randomised controlled 
trials and controlled clinical trials in this review was performed 
by two authors independently using the criteria recommended 
by the Cochrane Handbook (Higgins et al., 2011).
Data synthesis
We planned to combine the results of studies in a meta-
analysis, provided the interventions and outcomes were 
comparable, using a random effect model. The random effect 
model considers heterogeneity (differences) among included 
trials. However, the included studies were not comparable 
and did not provide sufficient details to be pooled in a meta-
analysis. We therefore limited the analysis to counting the 
number of studies with statistically significant results for each 
outcome considered.
Measures of treatment costs
A particular intervention could be considered economically 
efficient if its monetary benefits exceed its monetary costs. 
Unit costs, cost–benefit ratios, cost-effectiveness ratios, ICERs 
and acceptability curves were used to evaluate costs and the 
relative cost-effectiveness of interventions.
There are currently no agreed-upon methods for pooling 
combined estimates of cost-effectiveness (e.g. ICERSs, 
cost–utility ratios, cost–benefit ratios), extracted from 
multiple economic evaluations, using meta-analysis or other 
quantitative synthesis methods. However, if estimates measure 
costs in a common metric, these can be pooled using a meta-
analysis. However, extreme caution is required and, prior to any 
decision to pool estimates using a meta-analysis, particular 
attention should be given to whether or not the metric in 
question has equivalent meaning across studies.
FIGURE 2
Flow chart of study assessment and selection
Records identied through database searching 
(PubMed: 1 529; EMBASE: 676; CINAHL: 230; Web of 
Science: 564; CENTRAL: 856; DARE: 37; NHSEED: 34)
(n = 3 892)
Additional records identied 
through other sources
(n = 3)
Records after duplicates removed
(n = 2 584)
Records screened 
(n = 2 584)
Full-text articles assessed for eligibility
(n = 188 references)
Studies included in qualitative synthesis
(n = 61 references; 38 studies + 3 studies for the economic analysis)
Records excluded
(n = 2 309)
Studies awaiting classication
(n = 13 references)
Full-text articles excluded, with
reasons (n = 111 references)
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The pursuit of efficiency in the healthcare sector requires 
that priority be given to those treatments that provide the 
greatest benefits per unit of cost. Different approaches 
have been used to assess the benefits and costs of health 
interventions. Here, some of the methods used to compare 
costs with benefits of health interventions are described.
Cost-benefit analysis is a method of comparing the costs 
and the (money-valued) benefits of various courses of 
action. It entails systematic comparisons of all the relevant 
costs and benefits of the proposed alternative schemes, 
with a view to determining (a) which scheme, or size 
of scheme, or combination of schemes, maximises the 
difference between the benefits and the costs, or (b) the 
magnitude of the benefit that can result from schemes 
having various costs.
Cost-effectiveness analysis is a method of comparing the 
opportunity cost of various courses of action that have 
the same benefit or comparing alternatives. Benefits are 
normally quantified as health outcomes and measured, 
for instance, in natural units such as life years saved or 
improvements in functional status (e.g. blood pressure). 
This approach is used when benefits are difficult to value 
monetarily. It has similarities with cost–benefit analysis, but 
the benefits, instead of being expressed in monetary terms 
or as several non-commensurable benefits, are expressed in 
terms of a homogeneous index of health results achieved, 
for instance measured in terms of related deaths. Therefore, 
as cost and benefits are measured in non-comparable 
units, their ratios provide a yardstick of the relative 
efficiency of alternative interventions. A major limitation 
of a cost-effectiveness analysis is its inability to compare 
interventions with different natural effects.
Cost-utility analysis is an adaption of cost-effectiveness 
analysis that measures benefits using a utility-based 
measure such as quality-adjusted life years (QALYs). QALYs 
provide a common currency for measuring the extent of 
health gains that result from healthcare interventions. The 
health gain is measured by the number of years of life that 
would be added by each intervention (life expectancy) 
and the quality of life that each person assesses that each 
healthcare intervention provides. NICE defines the QALY 
as a ‘measure of a person’s length of life, weighted by 
a valuation of their health-related quality of life’.
The incremental cost-effectiveness ratio (ICER) is the ratio 
between the difference in cost between one therapeutic and 
another and their difference in benefits:
ICER = (C1 – C2) / (E1 – E2)
where C1 and E1 are the cost and effect, respectively, of the 
intervention or treatment group and where C2 and E2 are 
the cost and effect, respectively, of the control group. Costs 
are usually described in monetary units, while benefits or the 
effect on health status are frequently measured in terms of 
QALYs.
The best-known institution that has adopted the 
‘incremental cost-effectiveness ratio’ evaluation criteria is 
NICE, UK.
Sources: Appleby, 2016; Culyer, 2005; National Institute for 
Health and Care Excellence, 2007.
Economic evaluation tools for health interventions
EMCDDA PAPERS I How can contingency management support treatment for substance use disorders? A systematic review
7 / 46
I Results
I Results of the bibliographic search
After removing duplicates, a total of 2 584 records were 
retrieved; 275 titles were judged as potentially relevant (Figure 
2). They were grouped according to their types of participants 
as follows: opioid-dependent patients, cocaine-dependent 
patients, patients dependent on opioids and/or cocaine, 
cannabis-dependent patients, stimulant-dependent patients 
and polysubstance-abusing or -dependent patients. Given 
the huge number of potentially relevant records identified, we 
acquired the full-text version of 185 records for more detailed 
evaluation and inclusion in our review, including those on 
opioid-dependent patients, cocaine-dependent patients, 
patients dependent on both opioids and cocaine, cannabis-
dependent patients and stimulant-dependent patients; we did 
not consider the studies on polysubstance-abusing patients, 
which will be analysed in a further review.
Results are presented separately for the five types of 
participants considered. Details of studies are available in 
Annex 1.
Cannabis-dependent patients
The full-text versions of 12 articles related to seven studies 
were acquired; all were excluded because none of them 
assessed the effectiveness of the CM approach in addition 
to a substitution or detoxification pharmacological treatment 
compared with pharmacological treatment alone (i.e. 
the inclusion criteria); the effectiveness of CM without 
pharmacological interventions has been studied in a previous 
publication (EMCDDA, 2015). See the references of the 
excluded studies on cannabis-dependent patients.
Stimulant-dependent patients
The full-text versions of 16 articles were acquired and one 
study (two articles) was included (Huber et al., 2001; Shoptaw 
et al., 2006), which included 229 methamphetamine-abusing 
or -dependent patients randomised to receive sertraline 
plus CM (n = 61), sertraline only (n = 59), matching placebo 
plus CM (n = 54) or matching placebo only (n = 55). The 
CM intervention was given to patients with negative urine 
for methamphetamine metabolites. A voucher was given to 
patients in the CM intervention for their initial metabolite-
free sample, which was worth USD 2.50, and this increased 
in value by USD 1.25 for each consecutive metabolite-free 
sample. Each third consecutive metabolite-free sample earned 
a USD 10.00 bonus voucher. This study was conducted in the 
USA.
Effect of interventions
This study did not report data on patients’ retention in 
treatment, but patients in the CM intervention used less 
methamphetamine.
Cocaine-dependent patients
The full-text versions of 50 articles were acquired. Only three 
studies (five articles) were included (Jones et al., 2001, 2004; 
Schmitz et al., 2006, 2008, 2009), which, in total, enrolled 447 
patients who met the criteria for cocaine dependence (Jones 
et al., 2004; Schmitz et al., 2008, 2009). Patients included 
in the Schmitz et al. (2009) study were also dependent on 
alcohol; the mean age in this study was 37 years and 76 % of 
the participants were male.
Jones et al. (2004) assessed the efficacy of tryptophan 
compared with placebo, both with and without CM. Schmitz 
et al. (2008) assessed the efficacy of levodopa compared with 
placebo, with or without CM or cognitive behavioural therapy 
(CBT), and Schmitz et al. (2009) assessed the efficacy of 
naltrexone compared with placebo, with or without CM.
The CM intervention was the same in all of the studies: 
patients were rewarded for having urine sample negative for 
cocaine metabolites. The voucher for the initial metabolite-
free sample was worth USD 2.50 and increased in value by 
USD 1.25 for each consecutive metabolite-free sample. Each 
third consecutive metabolite-free sample earned a USD 10.00 
bonus voucher.
All three studies were conducted in the USA.
Effect of interventions
All of the studies assessed patients’ retention in treatment. 
None of the studies found significant differences between 
groups.
All of the studies assessed the mean percentages of urine 
positive or negative for cocaine metabolites; two of the three 
studies reported statistically significant results in favour of CM.
All the studies assessed continuous abstinence; two of the three 
studies reported statistically significant results in favour of CM.
 Patients dependent on cocaine and opioids
The full-text versions of 41 articles were acquired after 
being judged to be potentially relevant, and 14 studies (23 
articles) were included (Jones et al., 2001; Kosten et al., 2003; 
Oliveto et al., 2005; Petry and Martin, 2002; Petry et al., 2005, 
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Poling et al., 2006; Rawson et al., 2002; Rowan-Szal et al., 
2005; Silverman et al., 2004, 2007a,b; Umbricht et al., 2014; 
Winstanley et al., 2011). Three studies were classified as 
awaiting classification because only conference proceedings 
with incomplete information were retrieved. In total, the 14 
included studies enrolled 1 550 patients who met criteria for 
both cocaine and opioid dependence.
All the studies assessed the effectiveness of CM in addition 
to standard care (methadone maintenance plus counselling 
in all but two studies: in Kosten et al. (2003), buprenorphine 
maintenance was provided and, in Oliveto et al. (2005), LAAM 
maintenance at doses of 30 mg and 100 mg were provided). 
Four studies also assessed the efficacy of the addition of 
a pharmacological treatment: desipramine in Kosten et al. 
(2003), bupropione in Poling et al. (2006), topiramate in 
Umbricht et al. (2014) and fluoxetine in Winstanley et al. 
(2011). Two studies also assessed the effectiveness of two 
different amounts of monetary reinforcement (Petry et al., 
2007, 2014).
CM intervention differed among studies: in five studies, the 
CM was based on negative results in urine for cocaine alone 
(Petry et al., 2007; Rowan-Szal and Simpson, 2003; Silverman 
et al., 2007 a, b; Umbricht et al., 2014; Winstanley et al., 2011); 
in four studies it was based on negative results in urine for 
cocaine and opioids (Kosten et al., 2003; Oliveto et al., 2005; 
Petry and Martin, 2002; Poling et al., 2006); in one study it 
was based on negative results in urine for cocaine and alcohol 
(Petry et al., 2014); and, in Silverman et al. (2004), the CM 
of taking home methadone was based on negative results 
in urine for cocaine and opioids, whereas vouchers were 
based on negative results in urine for cocaine alone. In three 
studies (Jones et al., 2001; Petry et al., 2005; Rowan-Szal et 
al., 2005), the CM was based on negative results in urine for 
cocaine and attending a counselling session or achieving other 
individualised treatment goals. All but one study (Silverman 
et al., 2007a,b) gave vouchers or prizes with monetary values; 
in only one arm of the Silverman et al. (2004) study was the 
premium CM the taking home of methadone. In Silverman et 
al. (2007 a,b), the premium CM consisted in the possibility of 
continuing to work and earn money, while the control group 
had access to the therapeutic workplace irrespective of urine 
analysis results.
All of the studies were conducted in the USA.
Effect of interventions
All but two studies (Petry et al., 2014; Rowan-Szal et al., 
2005) assessed patients’ retention in treatment. Only 1 out 
of these 12 studies found a significant difference in favour of 
CM. Winstanley et al. (2011) reported that significantly more 
patients dropped out from the fluoxetine without CM group 
compared with the other three groups.
All but one study (Petry et al., 2007) assessed the mean 
percentages of positive or negative results in the urine for 
cocaine metabolites. Of these, 10 out of 13 studies reported 
statistically significant results in favour of CM. In Petry et 
al. (2014), the results were statistically significant for the 
group with higher monetary reinforcement only. Eight studies 
assessed continuous abstinence. All of these reported 
statistically significant results in favour of CM.
Eight studies assessed the mean percentages of positive or 
negative results in the urine for opioid metabolites. Two of 
these reported statistically significant results in favour of CM. 
Two studies assessed continuous abstinence, both of which 
reported statistically significant results in favour of CM.
Opioid-dependent patients
The full-text versions of 63 articles were acquired after being 
judged to be potentially relevant. Of these, 20 studies (31 
articles) were included (Bickel et al., 1997, 2008; Carroll et 
al., 2001, 2002; Chawarski et al., 2008; Chen et al., 2013; 
Chutuape et al., 1999, 2001; DeFulio et al., 2012; Dunn et al., 
2013–14 (reported as one study); Everly et al., 2011; Higgins 
et al., 1986; Hser et al., 2011; Jiang et al., 2012; McCaul et 
al., 1984; Neufeld et al., 2008; Nunes et al., 2006; Preston 
et al., 1999, 2000; Stitzer et al., 1992). Seven studies were 
classified as awaiting classification because only conference 
proceedings with incomplete information were retrieved.
In total, the 20 included studies enrolled 1 676 patients who 
met criteria for opioid dependence. The mean age of these 
studies was 36.5 years and 73.2 % of participants were male; 
one study (Chawarski et al., 2008) did not report the mean age 
or sex distribution of the participants.
Three types of pharmacological intervention were provided 
in the studies. Three studies assessed the efficacy of CM in 
addition to detoxification treatment (Bickel et al., 1997; Higgins 
et al., 1986; McCaul et al., 1984), 10 studies assessed CM in 
addition to maintenance or agonist substitution treatment 
(Bickel et al., 2008; Chawarski et al., 2008; Chen et al., 2013; 
Chutuape et al., 1999, 2001; Hser et al., 2011; Jiang et al., 
2012; Neufeld et al., 2008; Preston et al., 2000; Stitzer et 
al., 1992) and seven assessed CM in addition to naltrexone 
treatment in already detoxified patients (Carroll et al., 2001, 
2002; DeFulio et al., 2012; Dunn et al., 2013–14; Everly et al., 
2011; Nunes et al., 2006; Preston et al., 1999).
The CM intervention differed among the studies. In the three 
studies on detoxification treatment, CM included assessment 
of negative results in the urine for opioid. In the 10 studies 
on maintenance or agonist treatment, CM was based on the 
assessment of negative results in the urine for cocaine and 
opioids in three studies (Bickel et al., 2008; Chutuape et al., 
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1999, 2001); on negative results in the urine for opioids in 
two studies (Chawarski et al., 2008; Preston et al., 2000); 
on negative results in the urine for opioids, cocaine and 
benzodiazepines in one study (Stitzer et al., 1992); on negative 
results in the urine for opioids plus methadone ingestion in 
three studies (Chen et al., 2013; Hser et al., 2011; Jiang et al., 
2012); and on negative results in the urine for any illicit drug 
and attending a counselling session in one study (Neufeld 
et al., 2008). In the seven studies on naltrexone treatment, 
CM was based on negative results in the urine for opioids 
plus naltrexone ingestion in one study (Carroll et al., 2001); 
on negative results in the urine for opioids, cocaine and 
benzodiazepines plus naltrexone ingestion in two studies 
(Carroll et al., 2002; Nunes et al., 2006); and on naltrexone 
ingestion alone in four studies (DeFulio et al., 2012; Dunn et 
al., 2013–14; Everly et al., 2011; Preston et al., 1999).
In addition, the type of premium earned differed greatly among 
the studies. In the three studies on detoxification, it consisted 
in a monetary voucher (Bickel et al., 1997), a methadone 
dose increase (Higgins et al., 1986) or the taking home 
of methadone (McCaul et al., 1984). In the 10 studies on 
maintenance or agonist treatment, it consisted of the taking 
home of methadone in five studies (Chawarski et al., 2008; 
Chutuape et al., 1999, 2001; Neufeld et al., 2008; Stitzer et 
al., 1992), the remaining being monetary vouchers. In the 
Chinese study (Chen et al., 2013) the monetary voucher had 
to be spent on paying for treatment. In the seven studies on 
naltrexone, it consisted of monetary vouchers in four studies 
(Carroll et al., 2001, 2002; Nunes et al., 2006; Preston et al., 
1999) and permission to attend the therapeutic workplace and 
earning money in three studies (DeFulio et al., 2012; Dunn et 
al., 2013–14; Everly et al., 2011).
Three studies were conducted in China, one was conducted 
in Malaysia and all of the others were conducted in the USA. 
For a detailed description of the studies’ characteristics and 
results, see the tables of included studies in Annex 1.
Effect of interventions
Regarding the retention of patients in treatment:
 § Of the studies on maintenance or agonist treatment (of 
which eight assessed retention in treatment), only three 
found a significant difference in favour of CM.
 § Of the studies on detoxification treatment, all three 
assessed retention in treatment, and two found a significant 
difference in favour of CM.
 § Of the studies on naltrexone treatment, all seven assessed 
retention in treatment, and five found a significant 
difference in favour of CM.
Regarding patients’ use of opioids:
 § Of the studies on maintenance or agonist treatment: seven 
studies assessed the mean percentages of positive or 
negative results in the urine for opioid metabolites and three 
of these reported statistically significant results in favour of 
CM; four studies assessed continuous abstinence and three 
of these reported statistically significant results in favour of 
CM.
 § Of the studies on detoxification treatment: two studies 
assessed the mean percentages of positive or negative 
results in the urine for opioid metabolites and one of these 
reported statistically significant results in favour of CM; three 
studies assessed continuous abstinence and two of these 
reported statistically significant results in favour of CM.
 § Of the studies on naltrexone treatment: seven assessed the 
mean percentages of positive or negative results in the urine 
for opioid metabolites and one of these reported statistically 
significant results in favour of CM; two studies assessed 
continuous abstinence and one of these reported statistically 
significant results in favour of CM.
Regarding patients’ use of cocaine:
 § Of the studies on maintenance or agonist treatment: three 
studies assessed the mean percentages of positive or 
negative results in the urine for cocaine metabolites; none 
found a significant effect in favour of CM; none assessed 
continuous abstinence.
 § Of the studies on detoxification treatment, none assessed 
the patients’ use of cocaine.
 § Of the studies on naltrexone treatment: six studies assessed 
the mean percentages of positive or negative results in 
the urine for opioid metabolites and one of these reported 
statistically significant results in favour of CM; none 
assessed continuous abstinence.
Regarding patients’ use of opioids and cocaine:
 § Of the studies on maintenance or agonist treatment: two 
studies assessed the mean percentages of positive or 
negative results in the urine for cocaine metabolites and 
one of these found a significant effect in favour of CM; three 
studies assessed continuous abstinence and two of these 
found a significant effect in favour of CM.
 § Of the studies on detoxification treatment, none assessed 
patients’ use of opioids and cocaine.
 § Of the studies on naltrexone treatment, none assessed 
patients’ use of opioids and cocaine.
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TABLE 2
Quick guide to results
Participants Intervention Number of 
studies
Comparison Quick guide Outcomes
Methamphetamine 
use
CM (voucher of 
USD 2.50 for drug-free 
urine) + sertraline
1 study, n = 229 Matching placebo + Retention in treatment (n = 1/1)
+ Methamphetamine use (n = 1/1)
Cocaine 
dependence




Tryptophan or placebo – Retention in treatment (n = 0/3)
Levodopa with 
placebo and CBT
++ Reduction of drug use and 
abstinence (n = 2/3)
Cocaine and opioid 
dependence
CM (vouchers with 
monetary prizes 






counselling and some 
pharmacological 
interventions)
– Retention in treatment (n = 1/12)
++ Use of cocaine (n = 10/13)
++ Continuous cocaine abstinence 
(n = 8/8)
– Use of opioids (n = 2/8)
+ Continuous opioids abstinence 
(n = 2/2)
Opioid dependence CM (vouchers with 
monetary prizes) + opioid 
detoxification
3 studies, n = 98 Opioid detoxification 
only
++ Retention in treatment (n = 2/3)
+ Use of opioids (n = 1/2)







Naltrexone only + Retention in treatment (n = 5/7)
– Use of opioids (n = 1/7)
– Continuous opioids abstinence 
(n = 1/2)
– Use of cocaine (n = 1/6)
CM (vouchers with 
monetary prizes) + OST 




OST only or with 
counselling
– Retention in treatment (n = 3/8)
– Use of opioids (n = 3/7)
++ Continuous opioids abstinence 
(n = 3/4)
– Use of cocaine (n = 0/3)
– Use of opioids and cocaine 
(n = 1/2)
++ Continuous opioids and cocaine 
abstinence (n = 2/3)
Notes:
++ positive effect on outcome in the majority of studies
+ positive effect on outcome but with study limitations (i.e. two or fewer studies)
– no positive effect on outcome.
In the outcome column, the number of studies is shown in brackets (n = studies with positive results/total number of studies measuring the outcome).
I  Economic evaluations of contingency management
In systematic surveys of clinicians and programme directors, 
the most frequently cited obstacle to implementing CM in 
clinical practice was the relatively high cost of rewards/
incentives. Other considerations, such as ethical issues 
(e.g. paying drug users to do the right thing), practical 
considerations including the limited use of frequent urine 
screens to verify abstinence by many clinical programmes 
and limited knowledge to apply CM, were also frequently 
mentioned as barriers for a wider adoption of this approach 
(Carroll, 2014).
A question often raised is about the benefit of this approach 
to others in view of the costs of implementation. However, 
the number of studies analysing the costs of CM is relatively 
low. This section will describe the evidence on the economic 
evaluations of CM, in particularly trying to answer the following 
question: what are the costs and benefits of applying CM as an 
adjunctive treatment to standard care of drug use, compared 
with alternative therapies?
In January 2015, Shearer et al. (2015) performed a systematic 
literature review on economic evaluations of CM in relation 
to the treatment of illicit drug use. The inclusion criteria for 
evaluations were that (i) CM was applied as an adjunctive 
treatment to illicit drug users; (ii) the CM intervention was 
analysed by comparing it with treatment as usual (TAU) or 
other interventions, or different types or schedules of CM 
interventions were analysed; (iii) CM was evaluated based on 
any clinical outcomes; (iv) it was a full economic evaluation 
(defined as the comparison of differences in both the costs 
and the consequences of alternative interventions); and (v) 
the study was published between 1982 and 2013, inclusive. 
The main methodological procedures that have been identified 
as necessary to perform systematic reviews of cost–benefit 
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analyses were respected (National Institute for Health and 
Care Excellence, 2014; Drummond et al., 2005).
Shearer et al. (2015) concluded that, in all studies in which 
CM was adjunctive, treatment was more effective but also 
more costly. In addition, the authors stated that the evidence 
on cost-effectiveness was limited because these economic 
analyses were not generalisable. The studies that were 
included had small simple sizes and were conducted only in 
the USA. On the other hand, the authors stressed that a proper 
economic evaluation of this type of intervention should have 
taken into account more than simply the cost of treatment. 
In fact, CM may have an impact on various behaviours of the 
patients, including criminal activity, with consequent effects 
on costs of the judicial system. Shearer and colleagues stated 
that evidence of cost-effectiveness of CM, including criminal 
justice savings, would be an essential in supporting policy 
responses.
In this regard, the current literature survey identified two 
additional studies, not included in Shearer et al. (2015), 
which estimated the costs and benefits in relation to criminal 
dissuasion and activity. McCollister et al. (2009) and Sheidow 
et al. (2012) estimated the costs of criminal activity, of criminal 
systems (family courts and drug courts) and of different types 
of treatment for adolescents in the USA, using CM as one 
of the adjunctive treatments possible. They measured the 
impacts on adolescent substance use and criminal behaviours 
and estimated the costs and benefits of different alternatives. 
However, these two studies seem to have been based on the 
same small sample, sharing part of the research team (1). 
These studies differed in the methods applied to estimate cost-
effectiveness. While the first applied a multivariate analysis 
to evaluate effects, the second deducted the average cost-
effectiveness ratios (ACER) of alternatives. Both concluded 
that CM was the most costly alternative. While McCollister et 
al. (2009) concluded that the cost-effectiveness of CM was 
not statistically significantly different from the use of other 
evidence-based treatments, Sheidow et al. (2012) concluded 
that the use of CM as an adjunctive treatment was efficient 
for reducing all the outcomes of interest and the most cost-
effective in reducing polydrug use, alcohol use and heavy 
alcohol use. However, again, these studies suffer from a lack of 
external validity and their conclusions cannot be generalised to 
other contexts, as recognised by their authors.
Consequently, these studies support the conclusion of Shearer 
et al. (2015) that the evidence for cost-effectiveness is not yet 
strong enough to come to any firm conclusion to support the 
implementation of what may be a promising strategy of drug 
treatment programmes.
(1) Although the corresponding author common to both studies was contacted, 
no reply was received. 
I Discussion
Contingency management is applied for a variety of 
interventions and settings and the overall results show that CM 
often helps to keep people in treatment, and it provides overall 
positive findings with opioid and cocaine addicts, but this is less 
clear for other substances. Furthermore, even though evidence 
is not yet strong enough to be fully conclusive, it seems to 
suggest that adding CM to other treatment approaches 
increases costs but can be a promising strategy overall if 
economic effects are considered (see Table 3 for main results).
The CM approach has been studied under very different 
conditions and settings. The participants enrolled in the studies 
we analysed had problems related to stimulants, cocaine, 
opioids, and cocaine and opioids, or polysubstance problems. 
The CM approach was used as a stand-alone intervention, 
as an adjunct to other psychosocial interventions or in 
combination with pharmacological therapy. Pharmacological 
treatments also varied, both in the objective (detoxification 
or maintenance) and in the type of drug used. Finally, CM 
approaches also varied, both in the types of behaviour 
reinforced (drug abstinence in the majority of studies, but also 
attending psychosocial therapy groups or compliance with 
the pharmacological treatment) and in the type of reward. 
Most of the trials used monetary premium, but some used the 
TABLE 3
Description of main results








Results come from only 
one study, but they indicate 
that CM helps to decrease 
methamphetamine use 




CM (voucher of 
USD 2.50 for 
drug-free urine)
Positive effect of CM in 
reducing cocaine use but 
not in retaining people in 
treatment








CM not effective in increasing 
retention but very positive 
effect in reducing cocaine use 
and increasing continuous 








Significant effect of CM in 
retaining patients in treatment 
as well as in decreasing opioid 






Some positive effects of CM in 
retaining patients in treatment 
but no evidence of effect on 







Positive effects only for 
continuous opioids and 
cocaine abstinence, but no 
effect in decreasing use or 
retaining people in treatment
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possibility of taking home prescribed pharmaceuticals or the 
possibility of continuing to attend the therapeutic workplace.
The cost-effectiveness analysis benefited from a recent 
systematic literature survey, from which conclusions were 
drawn based on nine selected articles. These articles 
concerned the USA; focused mostly on drug addiction, 
including stimulants, opioids and cannabis; and included 
CM that rewarded abstinence or abstinence and treatment 
attendance, or adherence to anti-retroviral medication in 
HIV-positive methadone maintenance patients. All studies 
made economic evaluations based on data from randomised 
controlled trials, performing cost-effectiveness analysis or cost 
analysis from the perspective of the payers only. CM tended 
to make treatment more effective but also more costly. The 
authors complemented this analysis with two papers that 
assessed cost-effectiveness including judicial interventions 
costs, treatment costs and the decline in crime rates as 
additional outcomes. Again, the review suggests that CM 
makes treatment more expensive but conclusions depend upon 
the method used to assess cost-effectiveness. If the method 
used to evaluate the dominance of CM over alternatives was 
a multivariate analysis, the cost-effectiveness of CM is not 
significantly different from other strategies; if dominance is 
appraised with ACER, then treatment is significantly cost-
effective (on average). However, ACERs can be misleading 
for informing choices between interventions (Drummond 
et al., 2005). In addition, the applicability of these studies is 
limited by external validity considerations, which prevent these 
conclusions from being applied to other frameworks.
I Quality of the evidence
Overall, the retrieved studies had a low quality of reporting. The 
vast majority of the studies did not report information about 
random sequence generation for randomisation, and allocation 
of patients to groups was concealed. None of the studies was 
double blinded because it was not possible to blind participants 
and providers to the kind of intervention assessed. None of 
the trials reported information about blinding of the outcome 
assessor, but the outcomes considered were objective in all 
of the trials (retention in treatment and use of substances 
assessed by urine analysis); therefore, the risk of detection bias 
was judged to be low. Of all of the studies, 34 % were judged to 
be at high risk of attrition bias for the outcome substance of use 
because an intention-to-treat analysis was not done and the 
rate of drop out was greater than 30 %. Only five studies (13 %) 
did not report results about retention in treatment and were 
judged to be at high risk of selective reporting.
The quality of the evidence on the cost-effectiveness of CM 
varies. However, a minority of studies do not indicate the 
costing year, which prevents data from being revalued and, 
therefore, makes comparisons across studies difficult. Samples 
were also frequently small. Most studies did in fact take the 
‘service provider’ perspective of costs, but frequently did not 
explicitly state their analytical perspective.
I Limitations in the review process
The major limitation of our review is the fact that it was not 
possible to perform a meta-analysis of the results of primary 
studies and, thus, the necessity to base our conclusions on the 
number of studies with statistically significant results. This is 
because of the poor quality of reporting of the primary studies, 
which, in many cases, did not report the raw data but only 
the results of the statistical analysis in terms of the p-value 
or the results of regression analysis. Furthermore, the studies 
used different ways of measuring the outcomes of interest, 
making between-study comparisons difficult. For example, 
some studies looked for positive results in urine analysis and 
others looked for negative results, and continuous abstinence 
was measured over different time periods, with some studies 
counting the mean number of days or weeks of continuous 
abstinence while others counted the number of subjects 
achieving a predefined period of continuous abstinence.
We did not assess the risk of publication bias with a funnel 
plot, which is a graph that represents the risk that studies with 
negative results are underreported. Nevertheless, as the search 
strategy was comprehensive – including systematic inspection 
of websites of conference proceedings and bibliographic 
searches of many databases (without date and language 
restrictions) and the inspection of the reference lists of retrieved 
studies and already published systematic reviews – we consider 
that the probability is small that relevant studies on this topic 
have been missed, but the possibility that some unpublished 
studies have not been retrieved cannot be ruled out.
I Conclusions
Although limited, the present analysis shows that CM is 
a feasible and promising adjunct to treatment interventions for 
drug users.
Contingency management has been studied alongside various 
types of interventions provided in different settings. Overall, the 
study results show that CM can help keep people in treatment, 
and promote a reduction of opioid and cocaine problems in 
patients in opioid substitution treatment. Data on patients with 
other substance-related problems are less available for this 
analysis. The provision of CM as an adjunct to other treatment 
approaches increases costs but, even though evidence is 
not yet strong enough to conclude on cost-effectiveness, it 
seems to suggest that CM is a promising strategy overall if the 
economic effects are considered in the long term.
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I Included studies (primary source numbered)
Stimulant-dependent patients
1.  Shoptaw, S., Huber, A., Peck, J. et al. (2006), ‘Randomized, placebo-controlled trial of sertraline and 
contingency management for the treatment of methamphetamine dependence’, Drug and Alcohol 
Dependence 85, pp. 12–18.
 I  Huber, A., Shoptaw, S., Gulati, V. and Gonzales, R. (2001), ‘Sertraline and contingency 
management as treatment for methamphetamine dependence’, Proceedings of the 63rd 
Annual Scientific Meeting of the College on Problems of Drug Dependence, 12–17 June 2001, 
Scottsdale, Arizona, USA, S95.
Cocaine-dependent patients
1. Jones, H. E., Johnson, R. E., Bigelow, G. E., Silverman, K., Mudric, T. and Strain, E. C. (2004), ‘Safety 
and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: 
a randomized clinical trial’, American Journal on Addictions 13, pp. 421–437.
 I  Jones, H. E., Strain, E. C., Johnson, R. E., Stitzer, M. L. and Bigelow, G. E. (2001), ‘The efficacy 
of tryptophan and behavioral therapy for treating cocaine dependence: a randomized clinical 
trial’, Proceedings of the 12th Annual Meeting & Symposium of American Academy of Addiction 
Psychiatry, 13–16 December 2001, Ritz-Carlton, Amelia Island, Florida, USA.
2. Schmitz, J. M., Lindsay, J. A., Green, C. E., Herin, D. V., Stotts, A. L. and Moeller, F. G. (2009), ‘High-
dose naltrexone therapy for cocaine-alcohol dependence’, American Journal on Addictions 18, 
pp. 356–362.
3. Schmitz, J. M., Mooney, M. E., Moeller, F. G., Stotts, A. L., Green, C. and Grabowski, J. (2008), 
‘Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy 
platform’, Drug and Alcohol Dependence 94, pp. 142–150.
 I  Schmitz, J. M., Mooney, M. E., Stotts, A. L., Moeller, G. F. and Grabowski, J. (2006), ‘Randomized 
controlled trial of levodopa-carbidopa and behavior therapy for cocaine-dependent outpatients’, 
Proceedings of the 68th Annual Scientific Meeting of the College on Problems of Drug 
Dependence, 17–22 June, Scottsdale, Arizona, USA.
Patients dependent on both cocaine and opioids
1. Jones, H. E., Haug, N., Silverman, K., Stitzer, M. and Svikis, D. (2001), ‘The effectiveness of incentives 
in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant 
women’, Drug and Alcohol Dependence 61, pp. 297–306.
2. Kosten, T., Oliveto, A., Feingold, A. et al. (2003), ‘Desipramine and contingency management for 
buprenophine maintained cocaine abusers’, Drug and Alcohol Dependence 70, pp. 315–325.
 I  Kosten, T., Oliveto, A., Feingold, A., Sevarino, K. and Gonsai, K. (2001), ‘Desipramine and 
contingency management for buprenophine maintained cocaine abusers’, Drug and Alcohol 
Dependence 63 Suppl. 183.
3. Oliveto, A., Poling, J., Sevarino, K. A. et al. (2005), ‘Efficacy of dose and contingency management 
procedures in LAAM-maintained cocaine-dependent patients’, Drug and Alcohol Dependence 79, 
pp. 157–165.
 I  McGaugh, J. J., Mancino, M. J., Feldman, Z. and Oliveto, A. (2007), ‘Effect of PTSD diagnosis and 
contingency management procedures on cocaine use in opioid-dependent cocaine abusers 
maintained on low- vs. high-dose LAAM’, Proceedings of the 69th Annual Scientific Meeting of the 
College on Problems of Drug Dependence, 16–21 June 2007, Quebec City, Canada.
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